2019171-69-6 ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
61	自己免疫性溶血性貧血	2

61. 自己免疫性溶血性貧血

臨床試験数 : 146 / 薬物数 : 131 - (DrugBank : 59) / 標的遺伝子数 : 28 - 標的パスウェイ数 : 158

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-003160-27-HU (EUCTR)	19/04/2022	23/02/2022	A Randomized, Double-blind, Placebo-controlled Study to Evaluate Pegcetacoplan in Patients with Cold ...	A Phase 3, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy a ...	Patients with Cold Agglutinin Disease (CAD);Therapeutic area: Diseases [C] - Immune System Diseases ...	Trade Name: APL-2 Product Name: PEGCETACOPLAN (APL-2) Product Code: 2019171-69-6 INN or Proposed INN: P ...	Swedish Orphan Biovitrum AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	60	Phase 3	United States;Spain;Ukraine;Austria;Russian Federation;United Kingdom;Italy;France;Hungary;Canada;Bu ...
2	EUCTR2021-003160-27-ES (EUCTR)	04/04/2022	05/04/2022	A Randomized, Double-blind, Placebo-controlled Study to Evaluate Pegcetacoplan in Patients with Cold ...	A Phase 3, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy a ...	Patients with Cold Agglutinin Disease (CAD);Therapeutic area: Diseases [C] - Immune System Diseases ...	Trade Name: APL-2 Product Name: PEGCETACOPLAN (APL-2) Product Code: 2019171-69-6 INN or Proposed INN: P ...	Swedish Orphan Biovitrum AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	60	Phase 3	United States;Spain;Ukraine;Austria;Russian Federation;Italy;United Kingdom;France;Canada;Bulgaria;G ...

First Previous1Next Last